1. Rosa FW (1983) Teratogenicity of isotretinoin. Lancet 2: 513
2. Braun JT, Franciosi RA, Mastri AR, Drake RM, O’Niel BL (1984) Isotretinoin dysmorphic syndrome. Lancet 1: 506–507
3. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT et al (1985) Retinoic acid embryopathy. New Engl J Med 313: 837–841
4. Schardein JL (1993) Human studies: Retinoic Acid Embryopathy. In:JL Shardein (ed.): Chemically Induced Birth Defects. Marcel Dekker, New York, 558–567
5. Teratology Society (1991) Recommendations for Isotretinoin use in woman of childbearing potential. Teratology 44: 1–6